123 related articles for article (PubMed ID: 37981865)
1. Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype.
Pittaro A; Crivelli F; Orlando G; Napoli F; Zambelli V; Guerrera F; Sobrero S; Volante M; Righi L; Papotti M
Am J Surg Pathol; 2024 Feb; 48(2):204-211. PubMed ID: 37981865
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary Adenocarcinomas of Low Malignant Potential: Proposed Criteria to Expand the Spectrum Beyond Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
Yambayev I; Sullivan TB; Suzuki K; Zhao Q; Higgins SE; Yilmaz OH; Litle VR; Moreira P; Servais EL; Stock CT; Quadri SM; Williamson C; Rieger-Christ KM; Burks EJ
Am J Surg Pathol; 2021 Apr; 45(4):567-576. PubMed ID: 33177339
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
4. Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee.
Thunnissen E; Beasley MB; Borczuk A; Dacic S; Kerr KM; Lissenberg-Witte B; Minami Y; Nicholson AG; Noguchi M; Sholl L; Tsao MS; Le Quesne J; Roden AC; Chung JH; Yoshida A; Moreira AL; Lantuejoul S; Pelosi G; Poleri C; Hwang D; Jain D; Travis WD; Brambilla E; Chen G; Botling J; Bubendorf L; Mino-Kenudson M; Motoi N; Chou TY; Papotti M; Yatabe Y; Cooper W;
J Thorac Oncol; 2023 Apr; 18(4):447-462. PubMed ID: 36503176
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
[TBL] [Abstract][Full Text] [Related]
6. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger KR; Yatabe Y; Beer DG; Powell CA; Riely GJ; Van Schil PE; Garg K; Austin JH; Asamura H; Rusch VW; Hirsch FR; Scagliotti G; Mitsudomi T; Huber RM; Ishikawa Y; Jett J; Sanchez-Cespedes M; Sculier JP; Takahashi T; Tsuboi M; Vansteenkiste J; Wistuba I; Yang PC; Aberle D; Brambilla C; Flieder D; Franklin W; Gazdar A; Gould M; Hasleton P; Henderson D; Johnson B; Johnson D; Kerr K; Kuriyama K; Lee JS; Miller VA; Petersen I; Roggli V; Rosell R; Saijo N; Thunnissen E; Tsao M; Yankelewitz D
J Thorac Oncol; 2011 Feb; 6(2):244-85. PubMed ID: 21252716
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
8. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.
Sasada S; Nakayama H; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Murakami S; Ito H; Okada M
Ann Thorac Surg; 2015 Mar; 99(3):956-60. PubMed ID: 25620597
[TBL] [Abstract][Full Text] [Related]
9. Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma.
Weichert W; Warth A
Curr Opin Pulm Med; 2014 Jul; 20(4):309-16. PubMed ID: 24811831
[TBL] [Abstract][Full Text] [Related]
10. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.
Kadota K; Yeh YC; D'Angelo SP; Moreira AL; Kuk D; Sima CS; Riely GJ; Arcila ME; Kris MG; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Aug; 38(8):1118-27. PubMed ID: 25029118
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
12. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
[TBL] [Abstract][Full Text] [Related]
13. Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease.
Campos-Parra AD; Avilés A; Contreras-Reyes S; Rojas-Marín CE; Sánchez-Reyes R; Borbolla-Escoboza RJ; Arrieta O
Eur Respir J; 2014 May; 43(5):1439-47. PubMed ID: 24435003
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of the 3-tier classification according to the proportion of morphological patterns for patients with pathological stage I invasive lung adenocarcinoma.
Osawa J; Shimada Y; Maehara S; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Matsubayashi J; Ikeda N
Gen Thorac Cardiovasc Surg; 2021 Jun; 69(6):943-949. PubMed ID: 33385289
[TBL] [Abstract][Full Text] [Related]
15. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
17. The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation.
Wang Y; Wang R; Zheng D; Han B; Zhang J; Zhao H; Luo J; Zheng J; Chen T; Huang Q; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Oct; 143(10):2095-2104. PubMed ID: 28616702
[TBL] [Abstract][Full Text] [Related]
18. Lumican is overexpressed in lung adenocarcinoma pleural effusions.
Cappellesso R; Millioni R; Arrigoni G; Simonato F; Caroccia B; Iori E; Guzzardo V; Ventura L; Tessari P; Fassina A
PLoS One; 2015; 10(5):e0126458. PubMed ID: 25961303
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern.
Young TJ; Salehi-Rad R; Ronaghi R; Yanagawa J; Shahrouki P; Villegas BE; Cone B; Fishbein GA; Wallace WD; Abtin F; Barjaktarevic I
Med Sci (Basel); 2022 Jun; 10(3):. PubMed ID: 35893116
[TBL] [Abstract][Full Text] [Related]
20. Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma.
Wang YT; Chang IC; Chen CY; Hsia JY; Lin FC; Chao WR; Ke TY; Chen YT; Chen CJ; Hsieh MS; Huang SF
Thorac Cancer; 2023 Feb; 14(6):592-601. PubMed ID: 36594111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
